NO983849L - Peptidderivater - Google Patents

Peptidderivater

Info

Publication number
NO983849L
NO983849L NO983849A NO983849A NO983849L NO 983849 L NO983849 L NO 983849L NO 983849 A NO983849 A NO 983849A NO 983849 A NO983849 A NO 983849A NO 983849 L NO983849 L NO 983849L
Authority
NO
Norway
Prior art keywords
peptide
Prior art date
Application number
NO983849A
Other languages
English (en)
Norwegian (no)
Other versions
NO983849D0 (no
Inventor
Ronald Cotton
Philip Neil Edwards
Richard William Arthur Luke
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603855.9A external-priority patent/GB9603855D0/en
Priority claimed from GBGB9620819.4A external-priority patent/GB9620819D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO983849D0 publication Critical patent/NO983849D0/no
Publication of NO983849L publication Critical patent/NO983849L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO983849A 1996-02-23 1998-08-21 Peptidderivater NO983849L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9603855.9A GB9603855D0 (en) 1996-02-23 1996-02-23 Peptide derivatives
GBGB9620819.4A GB9620819D0 (en) 1996-10-05 1996-10-05 Chemical compounds
PCT/GB1997/000438 WO1997031023A1 (fr) 1996-02-23 1997-02-18 Derives peptidiques

Publications (2)

Publication Number Publication Date
NO983849D0 NO983849D0 (no) 1998-08-21
NO983849L true NO983849L (no) 1998-10-21

Family

ID=26308795

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983849A NO983849L (no) 1996-02-23 1998-08-21 Peptidderivater

Country Status (29)

Country Link
US (1) US6087336A (fr)
EP (1) EP0882066B1 (fr)
JP (1) JP3468528B2 (fr)
KR (1) KR19990087123A (fr)
CN (1) CN1116305C (fr)
AR (1) AR005974A1 (fr)
AT (1) ATE196152T1 (fr)
AU (1) AU722877C (fr)
BR (1) BR9707720A (fr)
CA (1) CA2242809A1 (fr)
CZ (1) CZ266398A3 (fr)
DE (1) DE69703032T2 (fr)
DK (1) DK0882066T3 (fr)
ES (1) ES2151716T3 (fr)
GB (1) GB9702377D0 (fr)
GR (1) GR3034361T3 (fr)
HK (1) HK1015383A1 (fr)
HR (1) HRP970099B1 (fr)
HU (1) HU222198B1 (fr)
ID (1) ID16037A (fr)
IL (1) IL125804A0 (fr)
NO (1) NO983849L (fr)
NZ (1) NZ330944A (fr)
PL (1) PL328486A1 (fr)
PT (1) PT882066E (fr)
SK (1) SK114998A3 (fr)
TR (1) TR199801614T2 (fr)
TW (1) TW492978B (fr)
WO (1) WO1997031023A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
PL330348A1 (en) * 1996-06-07 1999-05-10 Zeneca Ltd Peptidic derivatives
GB9621836D0 (en) 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) * 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
GB9625865D0 (en) * 1996-12-12 1997-01-29 Zeneca Ltd Peptides
GB9809021D0 (en) 1998-04-29 1998-06-24 Zeneca Ltd Chemical process
US6262080B1 (en) 1998-12-31 2001-07-17 Avantis Pharmaceuticals Inc. 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase
EP1150976B1 (fr) * 1998-12-31 2003-02-26 Aventis Pharmaceuticals Inc. Amido-lactames (3-thio-substitues) inhibiteurs de la metalloproteinase matricielle
GB9912911D0 (en) * 1999-06-04 1999-08-04 Zeneca Ltd Chemical process
US6485740B1 (en) * 2000-03-14 2002-11-26 Yutoku Pharmaceutical Ind., Co., Ltd. Transdermal methotrexate preparations
GB0017979D0 (en) * 2000-07-22 2000-09-13 Astrazeneca Ab Chemical process
GB0130285D0 (en) 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0317733D0 (en) 2003-07-29 2003-09-03 Novartis Ag Organic compounds
EP2366448B1 (fr) * 2010-03-16 2016-07-27 Amminex Emissions Technology A/S Procédé et dispositif de dosage contrôlé d'un gaz avec une pression d'alimentation fluctuante
WO2014052647A2 (fr) * 2012-09-26 2014-04-03 President And Fellows Of Harvard College Peptides agrafés bloqués par la proline et leurs utilisations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) * 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
US4680283A (en) * 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
DE3711335A1 (de) * 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5331089A (en) * 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
EP0360390A1 (fr) * 1988-07-25 1990-03-28 Glaxo Group Limited Dérivés de spirolactames
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
AU8305491A (en) * 1990-08-01 1992-03-02 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
AU2468392A (en) * 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
ATE170868T1 (de) * 1993-06-04 1998-09-15 Vertex Pharma Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen
WO1995007707A1 (fr) * 1993-09-14 1995-03-23 Cytel Corporation Alteration de la reponse immunitaire a l'aide de peptides se liant a des alleles pan dr
WO1995026980A2 (fr) * 1994-04-01 1995-10-12 Immulogic Pharmaceutical Corporation Peptides haptines et leurs utilisations
EP0815123B1 (fr) * 1995-03-24 2001-10-04 Molecumetics, Ltd. Imitateurs de feuillets beta et leur utilisation en tant qu'inhibiteurs de protease
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
AU7604196A (en) * 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
AU722877C (en) 2002-12-05
HUP9901189A3 (en) 2000-07-28
TW492978B (en) 2002-07-01
CZ266398A3 (cs) 1998-11-11
HK1015383A1 (en) 1999-10-15
AU722877B2 (en) 2000-08-10
JP3468528B2 (ja) 2003-11-17
EP0882066A1 (fr) 1998-12-09
IL125804A0 (en) 1999-04-11
TR199801614T2 (xx) 1998-11-23
AR005974A1 (es) 1999-07-21
AU1803597A (en) 1997-09-10
HRP970099B1 (en) 2001-10-31
HRP970099A2 (en) 1998-04-30
SK114998A3 (en) 1999-02-11
BR9707720A (pt) 1999-04-06
JP2000508623A (ja) 2000-07-11
NO983849D0 (no) 1998-08-21
HU222198B1 (hu) 2003-05-28
GB9702377D0 (en) 1997-03-26
US6087336A (en) 2000-07-11
DE69703032T2 (de) 2001-04-12
CA2242809A1 (fr) 1997-08-28
DK0882066T3 (da) 2000-12-18
DE69703032D1 (de) 2000-10-12
HUP9901189A2 (hu) 1999-08-30
PT882066E (pt) 2000-12-29
CN1116305C (zh) 2003-07-30
PL328486A1 (en) 1999-02-01
WO1997031023A1 (fr) 1997-08-28
EP0882066B1 (fr) 2000-09-06
KR19990087123A (ko) 1999-12-15
CN1213379A (zh) 1999-04-07
ES2151716T3 (es) 2001-01-01
ID16037A (id) 1997-08-28
ATE196152T1 (de) 2000-09-15
GR3034361T3 (en) 2000-12-29
NZ330944A (en) 2000-04-28

Similar Documents

Publication Publication Date Title
ATE208395T1 (de) Thiophenopyrimidine
NO985680L (no) Peptidderivater
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
NO983849D0 (no) Peptidderivater
FI970168A0 (fi) Peptidejä
DK0832553T3 (da) Mejetærsker
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
TR199701666A3 (tr) Sismanliga karsi proteinler
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
ATE235511T1 (de) Vielfältig verzweigte peptidkonstruktionen
NO981051D0 (no) Peptidderivater
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider
BR1100812A (pt) Peptìdeo
SE9504467D0 (sv) Peptide
ATE267568T1 (de) Epithese
ID17224A (id) Sediaan
BR9603463A (pt) Hidro-coleta
BR9600920A (pt) Otimizador-turbinado-nb
BR9600914A (pt) Lipodecantador
BR9600112A (pt) Conaço
BR7603492U (pt) Protemilk
BR7603380U (pt) Abratporta

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application